Sound waves zap liver tumors in groundbreaking trial
NCT ID NCT04573881
First seen Jan 12, 2026 · Last updated May 16, 2026 · Updated 15 times
Summary
This study tests a device that uses sound waves (histotripsy) to break apart liver tumors without needles or surgery. It includes 24 adults with liver cancer or tumors that have spread to the liver. The goal is to see if the treatment is safe and completely covers the tumor.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER METASTASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Istituto Clinico Humanitas - Humanitas Mirasole S.P.A.
Milan, Italy
-
Leeds Teaching Hospitals NHS Trust
Leeds, LS9 7TF, United Kingdom
-
Städtisches Klinikum Braunschweig gGmbH
Braunschweig, Germany
-
The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Newcastle, NE7 7DN, United Kingdom
-
Universitätsklinikum Magdeburg Klinik für Radiologie und Nuklearmedizin
Magdeburg, 39120, Germany
-
Vall d'Hebron
Barcelona, Spain
Conditions
Explore the condition pages connected to this study.